Preventing HCV Reinfection

HIV HCV Curriculum Logo

This lesson focuses on prevention of HCV reinfection prevention among people living with HIV who have been successfully treated for (or cured of) HCV in the past.

Download Slides

  1. Grady BP, Schinkel J, Thomas XV, Dalgard O. Hepatitis C virus reinfection following treatment among people who use drugs. Clin Infect Dis. 2013 Aug;57 Suppl 2:S105-10.
  2. Blackard JT, Sherman KE. Hepatitis C virus coinfection and superinfection. J Infect Dis. 2007 Feb 15;195(4):519-24.
  3. Islam N, Krajden M, Shoveller J, et al; British Columbia Hepatitis Testers Cohort (BC-HTC) team. Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study. Lancet Gastroenterol Hepatol. 2017 Mar;2(3):200-210.
  4. Martinello M, Grebely J, Petoumenos K, et al. HCV reinfection incidence among individuals treated for recent infection. J Viral Hepat. 2017 May;24(5):359-370.
  5. Young J, Rossi C, Gill J, et al; Canadian Co-infection Cohort Investigators. Risk factors for hepatitis C virus reinfection after sustained virologic response in patients coinfected with HIV. Clin Infect Dis. 2017 May 1;64(9):1154-1162.
  6. Des Jarlais DC, Nugent A, Solberg A, Feelemyer J, Mermin J, Holtzman D. Syringe service programs for persons who inject drugs in urban, suburban, and rural areas — United States, 2013. MMWR Morb Mortal Wkly Rep. 2015 Dec 11;64(48):1337-41.